The Role of 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer

Volume: 38 Number: 3 September 1, 2012
  • Gani Duman
  • Feyza Şen
  • Dudu Kumtepe
  • Burcu Sevilmiş
  • Erkan Güler
  • İlknur Karnal
  • Eray Alper
EN TR

The Role of 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer

Abstract

We aimed to determine the role of 18F-fluoro-deoxy-glucose positron-emission tomography/computed tomography (18F-FDG-PET/CT) in papillary thyroid cancer (PTC) patients with high thyroglobulin (Tg) levels whose whole-body radioiodine scans (WBIS) or radiological methods fail to show the recurrent/metastatic sites. We evaluated 28 PTC patients retrospectively who had undergone PET/CT scans between January 2008-June 2011 in our department. Focal increased 18F-FDG uptake with corresponding abnormal soft tissue lesion on CT was interpreted as pathologic and SUVmax was calculated. PET/CT results were compared with Tg levels, WBIS, radiological methods and histopathological results following surgery/biopsy. Relationship between PET/CT results and Tg levels and SUVmax were analyzed, statisti-cally. Of 28 PET/CT scans, 16 were true positive (TP), 7 were true negative, 4 were false positive (FP) and one was false negative. The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of PET/CT in detecting recurrent/metastatic foci was 94.1%, 63.6%, 82.1%, 80%, 87.5%, respectively. No statistically significant difference was found between Tg levels of PET/CT positive and negative groups. There was statistically significant difference in SUVmax (p=0.049) between TP and FP groups. 18F-FDG-PET/CT is a highly sensitive imaging method to detect suspected recurrence/metastases in PTC patients who have high Tg levels but negative WBIS.

Keywords

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Gani Duman This is me

Feyza Şen This is me

Dudu Kumtepe This is me

Burcu Sevilmiş This is me

Erkan Güler This is me

İlknur Karnal This is me

Eray Alper This is me

Publication Date

September 1, 2012

Submission Date

September 1, 2012

Acceptance Date

-

Published in Issue

Year 2012 Volume: 38 Number: 3

APA
Duman, G., Şen, F., Kumtepe, D., Sevilmiş, B., Güler, E., Karnal, İ., & Alper, E. (2012). The Role of 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer. Journal of Uludağ University Medical Faculty, 38(3), 185-191. https://izlik.org/JA52KA78AK
AMA
1.Duman G, Şen F, Kumtepe D, et al. The Role of 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer. Journal of Uludağ University Medical Faculty. 2012;38(3):185-191. https://izlik.org/JA52KA78AK
Chicago
Duman, Gani, Feyza Şen, Dudu Kumtepe, et al. 2012. “The Role of 18F-FDG PET CT in Patients With Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer”. Journal of Uludağ University Medical Faculty 38 (3): 185-91. https://izlik.org/JA52KA78AK.
EndNote
Duman G, Şen F, Kumtepe D, Sevilmiş B, Güler E, Karnal İ, Alper E (September 1, 2012) The Role of 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer. Journal of Uludağ University Medical Faculty 38 3 185–191.
IEEE
[1]G. Duman et al., “The Role of 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer”, Journal of Uludağ University Medical Faculty, vol. 38, no. 3, pp. 185–191, Sept. 2012, [Online]. Available: https://izlik.org/JA52KA78AK
ISNAD
Duman, Gani - Şen, Feyza - Kumtepe, Dudu - Sevilmiş, Burcu - Güler, Erkan - Karnal, İlknur - Alper, Eray. “The Role of 18F-FDG PET CT in Patients With Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer”. Journal of Uludağ University Medical Faculty 38/3 (September 1, 2012): 185-191. https://izlik.org/JA52KA78AK.
JAMA
1.Duman G, Şen F, Kumtepe D, Sevilmiş B, Güler E, Karnal İ, Alper E. The Role of 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer. Journal of Uludağ University Medical Faculty. 2012;38:185–191.
MLA
Duman, Gani, et al. “The Role of 18F-FDG PET CT in Patients With Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer”. Journal of Uludağ University Medical Faculty, vol. 38, no. 3, Sept. 2012, pp. 185-91, https://izlik.org/JA52KA78AK.
Vancouver
1.Gani Duman, Feyza Şen, Dudu Kumtepe, Burcu Sevilmiş, Erkan Güler, İlknur Karnal, Eray Alper. The Role of 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic I-131 Negative Papillary Thyroid Cancer. Journal of Uludağ University Medical Faculty [Internet]. 2012 Sep. 1;38(3):185-91. Available from: https://izlik.org/JA52KA78AK

ISSN: 1300-414X, e-ISSN: 2645-9027

Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
2023